OrthoPediatrics Secures Exclusive U.S. Distribution of Metal-Free OSSIOfiber Implants
KIDS•OrthoPediatrics inked an exclusive U.S. distribution agreement with OSSIO to supply bio-integrative OSSIOfiber implants to children’s hospitals nationwide, expanding its pediatric orthopedics portfolio. OSSIOfiber’s metal-free fixation gradually integrates into bone over 18–24 months, reducing secondary hardware removal surgeries and associated costs.
1. Exclusive Distribution Deal
OrthoPediatrics has entered an exclusive agreement with OSSIO to distribute OSSIOfiber implants to U.S. children’s hospitals nationwide, marking its first bio-integrative fixation product offering.
2. Innovative Bio-integrative Technology
OSSIOfiber implants are made from a proprietary natural mineral fiber blend that matches metal fixations' initial strength and fully integrates into the patient’s bone within 18–24 months, eliminating the need for hardware removal surgeries.
3. Strategic Growth Implications
The partnership expands OrthoPediatrics’ product portfolio in trauma and deformity segments, addresses unmet pediatric needs, reduces secondary procedure risks and costs for young patients, and strengthens the company’s long-term growth potential.
